Unlock all Features See Plans and Pricing

Serving leading biopharmaceutical companies globally:

Merck
Baxter
Medtronic
Boehringer Ingelheim
Mallinckrodt
Colorcon

Last Updated: January 27, 2023

CLINICAL TRIALS PROFILE FOR EPIPEN


✉ Email this page to a colleague

« Back to Dashboard

▶ Start for $1
Remove trial restrictions


All Clinical Trials for Epipen

Trial ID Title Status Sponsor Phase Start Date Summary
NCT00434421 ↗ Sublingual Cockroach Safety in Adults With Cockroach Allergy & Perennial Allergic Rhinitis With or Without Asthma Completed Inner-City Asthma Consortium Phase 1 2007-02-01 Immunotherapy may help reduce symptoms of allergy and asthma. Problems concerning compliance and adverse events with subcutaneous allergen immunotherapy have generated interest in delivering immunotherapy sublingually (under the tongue). The purpose of this study is to evaluate the safety of a cockroach extract given sublingually to people with perennial (year-round) allergic rhinitis, with or without asthma.
NCT00434421 ↗ Sublingual Cockroach Safety in Adults With Cockroach Allergy & Perennial Allergic Rhinitis With or Without Asthma Completed National Institute of Allergy and Infectious Diseases (NIAID) Phase 1 2007-02-01 Immunotherapy may help reduce symptoms of allergy and asthma. Problems concerning compliance and adverse events with subcutaneous allergen immunotherapy have generated interest in delivering immunotherapy sublingually (under the tongue). The purpose of this study is to evaluate the safety of a cockroach extract given sublingually to people with perennial (year-round) allergic rhinitis, with or without asthma.
NCT00809146 ↗ Paramedic Treatment of Prolonged Seizures by Intramuscular Versus Intravenous Anticonvulsant Medications Completed Medical University of South Carolina Phase 3 2009-06-01 The goal of this non-inferiority trial is to determine which type of routine care is the best for paramedics to stop someone from seizing.
NCT00809146 ↗ Paramedic Treatment of Prolonged Seizures by Intramuscular Versus Intravenous Anticonvulsant Medications Completed National Institute of Neurological Disorders and Stroke (NINDS) Phase 3 2009-06-01 The goal of this non-inferiority trial is to determine which type of routine care is the best for paramedics to stop someone from seizing.
>Trial ID >Title >Status >Phase >Start Date >Summary

Clinical Trial Conditions for Epipen

Condition Name

Condition Name for Epipen
Intervention Trials
Anaphylaxis 2
Intracranial Aneurysm 1
Total Knee Arthroplasty 1
Local Anesthesia 1
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Condition MeSH

Condition MeSH for Epipen
Intervention Trials
Anaphylaxis 2
Rhinitis, Allergic 2
Rhinitis 2
Urticaria 1
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Locations for Epipen

Trials by Country

Trials by Country for Epipen
Location Trials
United States 40
Croatia 1
Ukraine 1
Sweden 1
Serbia 1
This preview shows a limited data set
Subscribe for full access, or try a Trial

Trials by US State

Trials by US State for Epipen
Location Trials
Maryland 4
New York 3
Minnesota 2
California 2
Georgia 2
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Progress for Epipen

Clinical Trial Phase

Clinical Trial Phase for Epipen
Clinical Trial Phase Trials
Phase 4 3
Phase 3 3
Phase 2/Phase 3 1
[disabled in preview] 2
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Status

Clinical Trial Status for Epipen
Clinical Trial Phase Trials
Completed 8
Withdrawn 1
Not yet recruiting 1
[disabled in preview] 1
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Sponsors for Epipen

Sponsor Name

Sponsor Name for Epipen
Sponsor Trials
National Institute of Allergy and Infectious Diseases (NIAID) 2
Inner-City Asthma Consortium 1
University of Louisville 1
[disabled in preview] 1
This preview shows a limited data set
Subscribe for full access, or try a Trial

Sponsor Type

Sponsor Type for Epipen
Sponsor Trials
Other 10
Industry 5
NIH 3
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Colorcon
Harvard Business School
Dow
Mallinckrodt
Johnson and Johnson
McKesson

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.